BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25160933)

  • 1. Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy.
    Galli L; Spagnuolo V; Poli A; Salpietro S; Gianotti N; Cossarini F; Carbone A; Nozza S; Bossolasco S; Bigoloni A; Lazzarin A; Castagna A
    AIDS; 2014 Oct; 28(16):2407-15. PubMed ID: 25160933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
    Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
    AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies.
    Spagnuolo V; Galli L; Salpietro S; Gianotti N; Guffanti M; Cossarini F; Bigoloni A; Cinque P; Bossolasco S; Travi G; Fumagalli L; Lazzarin A; Castagna A
    Int J Cancer; 2012 Jun; 130(12):2990-6. PubMed ID: 21796633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer incidence in people living with HIV/AIDS in Israel, 1981-2010.
    Zohar M; Micha B
    AIDS Res Hum Retroviruses; 2015 Sep; 31(9):873-81. PubMed ID: 25941873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.
    Monforte Ad; Abrams D; Pradier C; Weber R; Reiss P; Bonnet F; Kirk O; Law M; De Wit S; Friis-Møller N; Phillips AN; Sabin CA; Lundgren JD;
    AIDS; 2008 Oct; 22(16):2143-53. PubMed ID: 18832878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era.
    Silverberg MJ; Abrams DI
    Curr Opin Oncol; 2007 Sep; 19(5):446-51. PubMed ID: 17762569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients: role of antiretroviral therapy.
    Masiá M; Padilla S; Álvarez D; López JC; Santos I; Soriano V; Hernández-Quero J; Santos J; Tural C; del Amo J; Gutiérrez F;
    AIDS; 2013 Jan; 27(2):181-9. PubMed ID: 23018442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study.
    Prosperi MC; Cozzi-Lepri A; Castagna A; Mussini C; Murri R; Giacometti A; Torti C; Costantini A; Narciso P; Ghinelli F; Antinori A; d'Arminio Monforte A;
    Clin Infect Dis; 2010 May; 50(9):1316-21. PubMed ID: 20297953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era.
    Albini L; Calabresi A; Gotti D; Ferraresi A; Festa A; Donato F; Magoni M; Castelli F; Quiros-Roldan E
    AIDS Res Hum Retroviruses; 2013 Aug; 29(8):1097-104. PubMed ID: 23581483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.
    Lapadula G; Cozzi-Lepri A; Marchetti G; Antinori A; Chiodera A; Nicastri E; Parruti G; Galli M; Gori A; Monforte Ad;
    AIDS; 2013 Mar; 27(5):769-79. PubMed ID: 23719349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease.
    Borges ÁH; Lundgren JD; Ridolfo A; Katlama C; Antunes F; Grzeszczuk A; Blaxhult A; Mitsura VM; Doroana M; Battegay M; Gargalianos P; Mocroft A;
    AIDS; 2014 Nov; 28(17):2565-71. PubMed ID: 25574959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patients.
    Spagnuolo V; Galli L; Poli A; Salpietro S; Gianotti N; Piatti P; Cossarini F; Vinci C; Carini E; Lazzarin A; Castagna A
    BMC Infect Dis; 2017 Jan; 17(1):43. PubMed ID: 28061820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of AIDS defining & non-AIDS defining malignancies in north India.
    Sachdeva RK; Sharma A; Singh S; Varma S
    Indian J Med Res; 2016 May; 143(Supplement):S129-S135. PubMed ID: 27748287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.
    Calabresi A; Ferraresi A; Festa A; Scarcella C; Donato F; Vassallo F; Limina R; Castelli F; Quiros-Roldan E;
    HIV Med; 2013 Sep; 14(8):481-90. PubMed ID: 23560682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy.
    Yanik EL; Napravnik S; Cole SR; Achenbach CJ; Gopal S; Olshan A; Dittmer DP; Kitahata MM; Mugavero MJ; Saag M; Moore RD; Mayer K; Mathews WC; Hunt PW; Rodriguez B; Eron JJ
    Clin Infect Dis; 2013 Sep; 57(5):756-64. PubMed ID: 23735330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency Virus.
    Chammartin F; Mocroft A; Egle A; Zangerle R; Smith C; Mussini C; Wit F; Vehreschild JJ; d'Arminio Monforte A; Castagna A; Bailly L; Bogner J; de Wit S; Matulionyte R; Law M; Svedhem V; Tallada J; Garges HP; Marongiu A; Borges ÁH; Jaschinski N; Neesgaard B; Ryom L; Bucher HC;
    Clin Infect Dis; 2024 Apr; 78(4):995-1004. PubMed ID: 38092042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer incidence among HIV-positive women in British Columbia, Canada: Heightened risk of virus-related malignancies.
    Salters KA; Cescon A; Zhang W; Ogilvie G; Murray MC; Coldman A; Hamm J; Chiu CG; Montaner JS; Wiseman SM; Money D; Pick N; Hogg RS
    HIV Med; 2016 Mar; 17(3):188-95. PubMed ID: 26268461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short Communication: HIV RNA Levels Predict AIDS-Defining and Non-AIDS-Defining Cancers After Antiretroviral Therapy Initiation Among HIV-Infected Adults.
    Crum-Cianflone NF; Wang X; Ganesan A; Okulicz J; Weintrob A; Lalani T; Agan B
    AIDS Res Hum Retroviruses; 2015 May; 31(5):514-8. PubMed ID: 25417712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignancy Trends in HIV-Infected Patients Over the Past 10 Years in a Single-Center Retrospective Observational Study in the United States.
    Rihana N; Nanjappa S; Sullivan C; Velez AP; Tienchai N; Greene JN
    Cancer Control; 2018; 25(1):1073274818797955. PubMed ID: 30185062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growing problem of non-AIDS-defining malignancies in HIV.
    Pantanowitz L; Schlecht HP; Dezube BJ
    Curr Opin Oncol; 2006 Sep; 18(5):469-78. PubMed ID: 16894295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.